FDA’s Promising New Framework for Rare Genetic Diseases

This JAMA Forum discusses the opportunities and challenges facing US Food and Drug Administration (FDA) new approval paths for individualized therapies to treat rare genetic diseases.

from JAMA Health Forum New Online https://ift.tt/9bSWQZC